Complete Genomics Cancels Conference Call
From Complete Genomics (NASDAQ: GNOM) filing:
We will not be hosting a conference call to discuss our financial results for the second quarter, due to our ongoing review of strategic alternatives with our financial advisor Jefferies & Company.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.